Association of the combined parameters including the frequency of primary cilia, PD-L1, Smoothened protein, membranous I3-catenin and cytoplasmic I3-catenin expression with the outcome of patients with clear cell renal cell carcinoma

Warning

This publication doesn't include Faculty of Education. It includes Faculty of Medicine. Official publication website can be found on muni.cz.

Authors	ROZSYPALOVA Aneta ROSOVA Blanka FILIPOVA Alzbeta NIKOLOV Dimitar Hadzi CHLOUPKOVÁ Renata RICHTER Igor ZACHOVAL Roman MATEJ Radoslav MELICHAR Bohuslav BUCHLER Tomas DVORAK Josef
Year of publication	2024
Type	Article in Periodical
Magazine / Source	Biomedical Papers
MU Faculty or unit	Faculty of Medicine
Citation
Web	https://biomed.papers.upol.cz/corproof.php?tartkey=bio-000000-3573
Doi	http://dx.doi.org/10.5507/bp.2024.005
Keywords	clear cell renal carcinoma; primary cilia; programmed cell death protein ligand 1; smoothened protein; membranous beta-catenin; beta-catenin
Attached files	Association_of_the_combined_parameters_including_the_frequency_of_primary_cilia__PD-L1__Smoothened_protein__membranous_I3-catenin_and_cytoplasmic_I3-catenin_expression_with_the_outcome_of_patients_with_clear_cell_renal_.pdf
Description	Aims. The objective of this study was to investigate the association and combined prognostic significance of the PD -L1, Smoothened protein and beta-catenin expressions in patients with clear cell renal cell carcinoma (ccRCC). Methods.The PD -L1, Smoothened protein and beta-catenin expression were evaluated in 104 ccRCC patients. All studied tumor samples were acquired from nephrectomy specimens of primary tumors and not from biopsies or metastases. An indirect immunohistochemistry using polyclonal rabbit anti -Smoothened antibody, monoclonal mouse anti -human beta-catenin-1 antibody, immunohistochemical assay PD -L1 28-8 pharmDx using monoclonal rabbit anti -PD -L1 antibody and anti-VHL (C- terminal) rabbit antibody was used. Immunohistochemistry was scored semiquantitavely. Results. Median overall survival (OS) was significantly better in patients with lower PD -L1 expression (<= 5%), Smoothened protein (SMO) expression (<5%) or cytoplasmic beta-catenin expression (<= 75%) than in patients with higher expressions of these biomarkers (P<0.001, P=0.047, and P<0.001, respectively). Membranous beta-catenin showed an opposite effect with its lower expression (<= 75%) being associated with longer OS (P=0.020). There was significant association between PD -1 and PD -L1 expression (P=0.007) and significant association of tumor grade (WHO 2016) with membranous beta-catenin (P<0.001), cytoplasmic beta-catenin (P=0.005), pVHL (P=0.042), PD -L1 (P=0.049) and PD -1 (P=0.028) expression. Conclusion. The present study provides the first data on the potential association and combined prognostic significance of frequency of primary cilia, PD -L1, Smoothened protein and beta-catenin expression with the outcome in clear cell renal cell carcinoma.
Related projects:	National institute for cancer research